Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PH1
PH1
FDA approves label expansion of Alnylam’s Oxlumo for PH1
Pharmaceutical Business Review
Fri, 10/7/22 - 10:38 am
Alnylam
FDAA
Oxlumo
advanced primary hyperoxaluria
PH1
Alnylam phase 3 links lumasiran to 'clinically significant' improvement in infants
Fierce Biotech
Wed, 09/30/20 - 10:35 am
Alnylam
clinical trials
lumasiran
RNAi
PH1
Alnylam sets up 3rd potential RNAi approval with a showcase of positive lumasiran data
Endpoints
Sun, 06/7/20 - 10:32 pm
Alnylam
clinical trials
RNAi
lumasiran
PH1